Erdafitinib,Vinflunine,Docetaxel,Pembrolizumab
Janssen,pierre fabre,Merck
['cohort 1', 'bladder', 'urothelial', 'erdafitinib']
thor cohort 1 reported at #asco23. os and pfs benefit in erdafitinib in fgfr +ve patients in second/third line. #bladdercancer #urothelial 
🇲🇾🇬🇧 Consultant clinical oncologist. Prostate and bladder cancers. Brachytherapy. Views my own.